Abstract

ABSTRACT Universal antiretroviral therapy (ART) for pregnant and postpartum women in sub-Saharan Africa has required adaptations to service delivery. We compared national policies on differentiated HIV service delivery with facility-level implementation, and explored provider and user experiences in rural Malawi, Tanzania and South Africa. Four national policies and two World Health Organization guidelines on HIV treatment for pregnant and postpartum women published between 2013 and 2017 were reviewed and summarised. Results were compared with implementation data from surveys undertaken in 34 health facilities. Eighty-seven in-depth interviews were conducted with pregnant and post-partum women living with HIV, their partners and providers. In 2018, differentiated service policies varied across countries. None specifically accounted for pregnant or postpartum women. Malawian policies endorsed facility-based multi-month scripting for clinically-stable adult ART patients, excluding pregnant or breastfeeding women. In Tanzania and South Africa, national policies proposed community-based and facility-based approaches, for which pregnant women were not eligible. Interview data suggested some implementation of differentiated services for pregnant and postpartum women beyond stipulated policies in all settings. Although these adaptations were appreciated by pregnant and postpartum women, they could lead to frustrations among other users when criteria for fast-track services or multi-month prescriptions were not clear.

Highlights

  • In 2013, the World Health Organisation (WHO) recommended lifelong antiretroviral therapy (ART) for all pregnant women living with HIV, regardless of their health status (World Health Organisation, 2013)

  • The aim of this paper is to describe national policies on differentiated service delivery (DSD) in Malawi, Tanzania and South Africa, and to explore the formal and informal policy adaptation in the implementation of HIV services delivered to women within prevention of mother-to-child transmission (PMTCT) programmes in three rural African settings

  • We present the differentiated service delivery policies adopted by each country during the study period using the Where, Who, When framework (International AIDS Society, 2016)

Read more

Summary

Introduction

In 2013, the World Health Organisation (WHO) recommended lifelong antiretroviral therapy (ART) for all pregnant women living with HIV, regardless of their health status (known as Option B+) (World Health Organisation, 2013). By 2015, the recommendation was expanded to cover all adults living with HIV (World Health Organisation, 2015). This approach, widely known as Universal Test and Treat (UTT), was rapidly adopted by most Eastern and Southern African countries, including South Africa, Tanzania and Malawi in 2016 (UNAIDS, 2018).

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.